These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8718426)

  • 1. Gemcitabine in advanced breast cancer.
    Possinger K
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():55-9. PubMed ID: 8718426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced breast cancer: a phase II trial with gemcitabine.
    Carmichael J; Possinger K; Phillip P; Beykirch M; Kerr H; Walling J; Harris AL
    J Clin Oncol; 1995 Nov; 13(11):2731-6. PubMed ID: 7595731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of gemcitabine in previously platinum-treated ovarian cancer patients.
    Lund B; Hansen OP; Neijt JP; Theilade K; Hansen M
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():61-2. PubMed ID: 8718427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer.
    Possinger K; Kaufmann M; Coleman R; Stuart NS; Helsing M; Ohnmacht U; Arning M
    Anticancer Drugs; 1999 Feb; 10(2):155-62. PubMed ID: 10211545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.
    Akrivakis K; Schmid P; Flath B; Schweigert M; Sezer O; Mergenthaler HG; Possinger K
    Anticancer Drugs; 1999 Jul; 10(6):525-31. PubMed ID: 10885899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II activity of gemcitabine in advanced breast cancer.
    Carmichael J; Walling J
    Semin Oncol; 1996 Oct; 23(5 Suppl 10):77-81. PubMed ID: 8893887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer.
    Rha SY; Moon YH; Jeung HC; Kim YT; Sohn JH; Yang WI; Suh CO; Kim GE; Roh JK; Chung HC
    Breast Cancer Res Treat; 2005 Apr; 90(3):215-21. PubMed ID: 15830134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of gemcitabine in patients with advanced pancreatic cancer.
    Carmichael J; Fink U; Russell RC; Spittle MF; Harris AL; Spiessi G; Blatter J
    Br J Cancer; 1996 Jan; 73(1):101-5. PubMed ID: 8554969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-agent gemcitabine is active in previously treated metastatic breast cancer.
    Spielmann M; Llombart-Cussac A; Kalla S; Espié M; Namer M; Ferrero JM; Diéras V; Fumoleau P; Cuvier C; Perrocheau G; Ponzio A; Kayitalire L; Pouillart P
    Oncology; 2001; 60(4):303-7. PubMed ID: 11408796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II study.
    Steward WP; Dunlop DJ; Cameron C; Talbot DC; Kleisbauer JP; Thomas P; Guerin JC; Perol M; Sanson C; Dabouis G
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():33-7. PubMed ID: 8718423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study.
    Lüftner D; Flath B; Akrivakis C; Mergenthaler HG; Ohnmacht U; Arning M; Possinger K
    Invest New Drugs; 1998; 16(2):141-6. PubMed ID: 9848577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer.
    Schmid P; Akrivakis K; Flath B; Grosse Y; Sezer O; Mergenthaler HG; Possinger K
    Anticancer Drugs; 1999 Aug; 10(7):625-31. PubMed ID: 10507311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
    Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A phase II multicenter study of gemcitabine in non small cell lung cancers].
    Le Chevalier T; Gottfried M; Gatzemeier U; Shepherd F; Weynants P; Cottier B; Groen HJ; Rosso R; Mattson K; Cortes-Funes H; Tonato M; Burkes RL; Voi M; Ponzio A
    Bull Cancer; 1997 Mar; 84(3):282-8. PubMed ID: 9207875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial.
    Van Kooten M; Traine G; Cinat G; Cazap E; Comba AZ; Vicente H; Sena S; Nievas OR; Orlando M
    Br J Cancer; 1999 Nov; 81(5):846-9. PubMed ID: 10555756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer.
    Seo JH; Oh SC; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS; Kim AR; Lee JB; Koo BH
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):269-74. PubMed ID: 16763791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine/paclitaxel as first-line treatment of advanced breast cancer.
    Delfino C; Caccia G; Riva Gonzáles L; Mickiewicz E; Rodger J; Balbiani L; Flores Morales D; Zori Comba A; Brosio C
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):22-5. PubMed ID: 14768401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients.
    Gridelli C; De Maio E; Barbera S; Sannicolo M; Piazza E; Piantedosi F; Brancaccio L; Morabito A; Maione P; Renda F; Signoriello G; Perrone F;
    Lung Cancer; 2008 Jul; 61(1):67-72. PubMed ID: 18683299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
    Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO).
    Tibaldi C; Ricci S; Russo F; Bernardini I; Galli L; Chioni A; Orlandini C; Grosso AM; Pegna AL; Fabbri A; Innocenti F; Ferrari K; Tognarini L; Conte PF; Falcone A;
    Lung Cancer; 2005 Apr; 48(1):121-7. PubMed ID: 15777979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.